Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 45963-142

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 45963-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Bupropion Hydrochloride. (Image 1)

Chemical structure of Bupropion Hydrochloride, showing the molecular arrangement including a chlorophenyl ring, three methyl groups attached to nitrogen, and the hydrochloride component.*

FDA Label Image

300mg (Image 2)

Label for Bupropion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg by Actavis Pharma, Inc. The label indicates an oral tablet form with a package containing 30 tablets. It includes dosing instructions, storage, and dispensing information, along with the NDC 45963-142 and a bar code. The label also shows the Actavis logo and serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.